AN2 Therapeutics Inc
NASDAQ:ANTX
AN2 Therapeutics Inc
NASDAQ:ANTX
Price:
2.97
USD
-2.62%
Market Closed
Market Cap:
$81.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
AN2 Therapeutics Inc
NASDAQ:ANTX
|
US |
|
Eat & Beyond Global Holdings Inc
OTC:EATBF
|
CA |
|
Cranex Ltd
BSE:522001
|
IN |
|
BigBear.ai Holdings Inc
NYSE:BBAI
|
US |
|
I
|
Infomina Bhd
KLSE:INFOM
|
MY |
|
R
|
Red Dirt Metals Ltd
ASX:RDT
|
AU |
|
G
|
Gotion High tech Co Ltd
SZSE:002074
|
CN |
|
Pwr Holdings Ltd
ASX:PWH
|
AU |
|
Mallcom (India) Ltd
NSE:MALLCOM
|
IN |
|
HealthStream Inc
NASDAQ:HSTM
|
US |
|
A
|
American National Bankshares Inc
XBER:NBR
|
US |
|
GFL Ltd
NSE:GFLLIMITED
|
IN |
|
Castellana Properties Socimi SA
MAD:YCPS
|
ES |
|
M
|
Mitra Komunikasi Nusantara Tbk PT
IDX:MKNT
|
ID |
|
T
|
Turn Therapeutics Inc
NASDAQ:TTRX
|
US |
|
Chubb Ltd
NYSE:CB
|
CH |
|
A
|
AjinExTek Co Ltd
KOSDAQ:059120
|
KR |
|
Zhejiang Tiantie Industry Co Ltd
SZSE:300587
|
CN |
Income Statement
Earnings Waterfall
AN2 Therapeutics Inc
AN2 Therapeutics Inc
Income Statement
AN2 Therapeutics Inc
AN2 Therapeutics Inc
Currency: USD
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(42)
|
(51)
|
(57)
|
(63)
|
(70)
|
(72)
|
(71)
|
(65)
|
(55)
|
(50)
|
(41)
|
(37)
|
(38)
|
|
| Selling, General & Administrative |
(13)
|
(15)
|
(14)
|
(15)
|
(15)
|
(14)
|
(15)
|
(15)
|
(14)
|
(14)
|
(15)
|
(14)
|
(13)
|
|
| Research & Development |
(30)
|
(36)
|
(43)
|
(49)
|
(55)
|
(58)
|
(56)
|
(50)
|
(40)
|
(34)
|
(25)
|
(24)
|
(25)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
|
| Operating Income |
(42)
N/A
|
(51)
-20%
|
(57)
-12%
|
(63)
-11%
|
(70)
-10%
|
(72)
-3%
|
(71)
+1%
|
(65)
+9%
|
(55)
+16%
|
(50)
+8%
|
(41)
+17%
|
(37)
+10%
|
(38)
-2%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
1
|
2
|
3
|
4
|
0
|
4
|
5
|
4
|
5
|
5
|
4
|
3
|
3
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(41)
N/A
|
(49)
-19%
|
(54)
-12%
|
(60)
-10%
|
(65)
-8%
|
(66)
-2%
|
(65)
+2%
|
(61)
+6%
|
(51)
+16%
|
(46)
+11%
|
(38)
+17%
|
(34)
+10%
|
(35)
-4%
|
|
| Net Income | ||||||||||||||
| Income from Continuing Operations |
(41)
|
(49)
|
(54)
|
(60)
|
(65)
|
(66)
|
(65)
|
(61)
|
(51)
|
(46)
|
(38)
|
(34)
|
(35)
|
|
| Net Income (Common) |
(43)
N/A
|
(49)
-14%
|
(54)
-12%
|
(60)
-10%
|
(65)
-8%
|
(66)
-2%
|
(65)
+2%
|
(61)
+6%
|
(51)
+16%
|
(46)
+11%
|
(38)
+17%
|
(34)
+10%
|
(35)
-4%
|
|
| EPS (Diluted) |
-2.79
N/A
|
-2.52
+10%
|
-2.8
-11%
|
-2.32
+17%
|
-2.74
-18%
|
-2.21
+19%
|
-2.16
+2%
|
-2.04
+6%
|
-1.72
+16%
|
-1.52
+12%
|
-1.25
+18%
|
-1.13
+10%
|
-1.16
-3%
|
|
Switch to:
Switch to:
See Also
Discover More
